These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 6299087

  • 1. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS.
    Am J Cardiol; 1983 Mar 01; 51(5):826-30. PubMed ID: 6299087
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S.
    J Cardiogr; 1985 Mar 01; 15(1):163-80. PubMed ID: 2999267
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
    Eriksson P, Backman C, Bjerle P, Eriksson A, Holm S, Olofsson BO.
    Br Heart J; 1984 Sep 01; 52(3):321-6. PubMed ID: 6087862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
    Weston LT, Raybuck BD, Robinowitz M, Brinker JA, Oetgen WJ.
    Cathet Cardiovasc Diagn; 1986 Sep 01; 12(3):176-81. PubMed ID: 3015411
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Technetium TC 99m pyrophosphate myocardial scintigraphy in amyloidosis. Correlations with Doppler echocardiography].
    Fournier C, Grimon G, Rinaldi JP, Terral A, Boujon B, Adams A, Desgrez A, Blondeau M.
    Arch Mal Coeur Vaiss; 1993 Jul 01; 86(7):1009-15. PubMed ID: 8291935
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
    Goldstein SA, Lindsay J, Chandeysson PL, Nolan NG.
    Am J Cardiol; 1989 Mar 15; 63(11):752-3. PubMed ID: 2538049
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Symptomatic cardiac amyloidosis in an American family.
    Ruder MA, Alpert MA, Sanfelippo JF, Dix JD, Whiting RB.
    South Med J; 1984 Jul 15; 77(7):831-3. PubMed ID: 6330908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.